Press Releases Benitec Biopharma Inc.

Equities

BNTC

US08205P2092

Market Closed - Nasdaq Other stock markets 21:00:00 17/05/2024 BST			5-day change	1st Jan Change
9.49 ^USD	+0.21%		+2.59%	+193.81%

05-13	Benitec Biopharma Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	CI
04-22	Benitec Biopharma Inc. announced that it has received $40.000019 million in funding from a group of investors	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Benitec Biopharma Releases Third Quarter 2024 Financial Results and Provides Operational Update	05-13	AQ
Benitec Biopharma : Releases Third Quarter 2024 Financial Results and Provides Operational Update - Form 8-K	05-13	PU
Benitec Biopharma to Participate in the Citizens JMP Life Science Conference	05-01	AQ
Benitec Biopharma Reports Positive Interim Clinical Trial Data for First OPMD Subject Treated with BB-301 in Phase 1b/2a Study	04-18	AQ
Benitec Biopharma Announces Oversubscribed Private Placement Financing of $40.0 Million	04-18	AQ
Benitec Biopharma to Host Virtual R&D Day to Discuss BB-301 Clinical Program in Oculopharyngeal Muscular Dystrophy on April 18, 2024	04-09	AQ
Benitec Biopharma Releases Second Quarter 2024 Financial Results and Provides Operational Update	02-13	AQ
Benitec Biopharma Announces First Subject Dosed in Phase 1b/2a Clinical Trial for Gene Therapy Candidate BB-301 for the Treatment of Oculopharyngeal Muscular Dystrophy	11-30	AQ
Benitec Biopharma to Participate in a Fireside Chat at the 35th Annual Piper Sandler Healthcare Conference	11-17	AQ
Benitec Biopharma Releases First Quarter 2024 Financial Results and Provides Operational Update	11-13	AQ
Benitec Biopharma : Material Event - Form 8-K	29/09/23	PU
Benitec Biopharma Releases Full Year 2023 Financial Results and Provides Operational Update	21/09/23	AQ
Benitec Biopharma Inc. Announces Closing of $30 Million Underwritten Public Offering	11/08/23	AQ
Benitec Biopharma : Failure to Satisfy Listing Rule - Form 8-K	11/08/23	PU
Benitec Biopharma Inc. Announces Pricing of $30 Million Underwritten Public Offering	09/08/23	AQ
Benitec Biopharma Announces 1-for-17 Reverse Stock Split Effective July 26, 2023	25/07/23	AQ
Benitec Biopharma Receives FDA Clearance of the IND for BB-301 for the Treatment of Oculopharyngeal Muscular Dystrophy	26/06/23	AQ
BENITEC BIOPHARMA INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	15/05/23	AQ
Benitec Biopharma Releases Third Quarter 2023 Financial Results and Provides Operational Update	15/05/23	AQ
Benitec Biopharma to Present at the OPMD International Conference	08/05/23	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Benitec Biopharma Inc.

Equities

BNTC

US08205P2092

Press Releases

Filters